Medically reviewed by Dr Sin Yong · Last reviewed · 7 min read · Assessed personally by Dr Sin Yong · Jump to questions
Exosomes are nanoscale vesicles — tiny membrane parcels that cells release to carry signalling molecules to other cells. In aesthetics they are marketed as bottled regeneration. The honest physician's summary: genuinely interesting biology, early but growing clinical evidence, and a regulatory landscape where what's in the bottle varies enormously — which makes the source and the setting matter more than the word on the label.
WhatsApp Dr Sin Yong →Exosomes for skin are nanoscale extracellular vesicles, roughly 30 to 150 nanometres across, that cells release to carry proteins, lipids and RNA to other cells. In aesthetics they are typically applied topically after energy treatments, and products vary widely by source, so source and setting matter.
Cells talk to each other by post: they package signalling molecules into membrane vesicles — exosomes — and release them to be picked up by neighbours, where the cargo changes behaviour. The aesthetic hypothesis is direct: harvest exosomes from regenerative cell cultures and deliver their pro-repair signals to ageing or healing skin. The systematic-review literature finds genuinely encouraging early signals — improvements in skin texture, healing support after procedures — alongside the honest caveats of a young field: small trials, varied products and protocols [1,2].
Where data is most consistent: exosomes as an adjunct after energy-based treatments — applied to freshly lasered or microneedled skin, where reviews report faster settling and skin-quality gains [1]. Where marketing outruns evidence: exosomes as a standalone anti-ageing transformation, claims of 'stem cell results without stem cells', and the quiet blurring between very different products — a characterised human-cell-derived preparation and a plant-extract vesicle are not the same biology wearing the same name [2]. The scoping literature on the commercial landscape is blunt about this heterogeneity: what is in the bottle varies enormously between brands.
In Singapore and most jurisdictions, exosome products are used topically — typically applied immediately after fractional laser or microneedling, when channels in the skin allow penetration — as part of the recovery-and-result protocol rather than as an injected therapy. In Dr Sin Yong's practice that is exactly the slot they occupy when used: post-procedure support after platforms like the Tetra Pro or RF microneedling, chosen product by product on characterisation, not label poetry. For injected regenerative support, the evidence currently favours established biologicals — polynucleotides — over exosome injection, which remains outside the approved lane in most markets.
Replace a lifting treatment — signalling molecules do not reposition tissue. Substitute for diagnosis — 'regeneration' aimed at an undiagnosed condition is expensive hope. Erase the difference between products — source, characterisation and handling decide whether a vial contains biology or storytelling. And justify any injection outside the regulated lane — the setting and the supervision are part of what you are paying for, or should be.
“Exosome is a biology word doing marketing work — the same label covers characterised human-cell science and plant-extract storytelling, and the bottle won't tell you which you bought.”
— Dr Sin Yong
Use the short enquiry form instead →
Leave your name, mobile number and email and the clinic will contact you directly. No obligation.
Prefer a preliminary view first? You can also WhatsApp a photo of the area for Dr Sin Yong to review before you decide on a visit.
Early systematic reviews report genuine promise, especially as topical support after energy treatments. The field is young: small studies, varied products. 'Promising adjunct' is the honest current verdict.
Topical use after procedures has a reassuring reported profile in the review literature. The safety question is really a product question — source and characterisation vary enormously between brands.
In most jurisdictions including Singapore, exosome products are used topically, not injected — injectable regenerative support belongs to established, regulated biologicals like polynucleotides.
No — they share a name and a vesicle structure, not a biology. Human-cell-derived and plant-derived products carry entirely different cargo. Ask any clinic which they use and why.
On intact skin, penetration of large vesicles is questionable — the clinical logic favours post-procedure application when channels are open. As shelf skincare, the evidence is far thinner than the pricing.
Different molecules, different evidence maturity. Polynucleotides carry systematic-review-level injected evidence; exosomes are the promising newcomer in the topical-adjunct lane. They answer different questions.
Medically reviewed by Dr Sin Yong, MBBS (NUS), MRCS (Edinburgh) · Last updated 7 October 2026 · Editorial policy
| Option | What it does | What it cannot do | What to expect afterwards | Who it tends to suit |
|---|---|---|---|---|
| Topical exosomes after energy treatment | Applied to freshly lasered or microneedled skin as post-procedure support, chosen product by product. | Not a proven replacement for any established treatment; does not reposition tissue. | Recovery follows the underlying laser or microneedling procedure; discussed at consultation. | Skin already being treated with Tetra Pro or RF microneedling. |
| Polynucleotides (Rejuran) | Injected regenerative support with systematic-review-level evidence, according to the page. | A different molecule with a different evidence base from exosomes. | Discussed at consultation, once the area and plan are assessed. | Injected regenerative support, where evidence favours established biologicals. |
| Exosome skincare on intact skin | Applied to intact skin as shelf skincare. | Penetration of large vesicles is questionable, and the evidence is thin. | An everyday routine with no procedural recovery. | Those wanting a home product, with expectations set by thin evidence. |
| Exosome injection | Proposed to deliver regenerative signals into skin; evidence is limited. | No HSA-approved injectable exosome product; it remains outside the approved lane. | Established biologicals are discussed instead. | Not recommended at present; established injectables are discussed instead. |
| Laser or RF microneedling alone | Treats skin quality with the procedure itself, without an added exosome product. | Does not add the signalling cargo exosomes are proposed to carry. | Recovery follows the procedure; discussed at consultation. | Those preferring an established treatment without an adjunct. |